SMARCB1 and extraskeletal myxoid chondrosarcoma: This suggested that these last tumors were definitely not RT, but behaved also differently from ES, RMC and UC, being either known SMARCB1-deficient entities not included in our training set (eMPNST, extra-skeletal chondrosarcomas, etc...), or unknown other entities.